"10.1371_journal.pone.0007517","plos one","2009-10-20T00:00:00Z","Kerstin Wunderlich; Daniel Mayer; Charlene Ranadheera; Anne-Sophie Holler; Benjamin MÃ¤nz; Arnold Martin; Geoffrey Chase; Werner Tegge; Ronald Frank; Ulrich Kessler; Martin Schwemmle","Department of Virology, University of Freiburg, Freiburg, Germany; PiKe Pharma GmbH, Zurich, Switzerland; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland; Department of Chemical Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany","Conceived and designed the experiments: KW DM UK MS. Performed the experiments: KW DM CR ASH BM AM GC. Analyzed the data: KW DM CR ASH UK MS. Contributed reagents/materials/analysis tools: WT RF MS. Wrote the paper: UK MS.","The co-authors Ulrich Kessler and Charlene Ranadheera declare competing financial interests. UK is founder and CEO of PiKe Pharma GmbH and CR's work was partially funded by PiKe Pharma GmbH. They confirm that this does not alter their adherence to all the PLoS ONE policies on sharing data and materials.","2009","10","Kerstin Wunderlich","KW",11,TRUE,4,7,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
